Good news
Plenty of enthusiasm
Bad news
No clinical update.
New formulation behind schedule.
Neutral news
Zantrene brand name on the back burner.
Ann: Letter to Shareholders, page-12
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.95 |
Change
0.005(0.26%) |
Mkt cap ! $331.3M | |||
| Open | High | Low | Value | Volume |
| $1.93 | $1.96 | $1.91 | $91.41K | 47.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 335 | $1.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 1000 | 1 |
View Market Depth
| Last trade - 10.19am 16/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |